Rochester, MI12 Active Studies

Multiple Sclerosis Clinical Trials in Rochester, MI

Find 12 actively recruiting multiple sclerosis clinical trials in Rochester, MI. Connect with local research sites and explore new treatment options.

12
Active Trials
7
Sponsors
2,991
Enrolling

Recruiting Multiple Sclerosis Studies in Rochester

About Multiple Sclerosis Clinical Trials in Rochester

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 12 multiple sclerosis clinical trials recruiting participants in Rochester, MI. These studies are seeking a combined 2,991 participants. Research is being sponsored by Mayo Clinic, Seagen, a wholly owned subsidiary of Pfizer, Eli Lilly and Company and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in Rochester — FAQ

Are there multiple sclerosis clinical trials in Rochester?

Yes, there are 12 multiple sclerosis clinical trials currently recruiting in Rochester, MI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Rochester?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you about next steps.

Are clinical trials in Rochester free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rochester studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 12 active trials in Rochester are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated July 13, 2026 from ClinicalTrials.gov